Abstract
Background
The risk factors for the survival of elderly patients with oral squamous cell carcinoma (OSCC) are multifarious. Here, we developed a novel clinical signature to serve as an indicator of prognosis in these patients.
Materials and methods
Clinicopathological data were collected for 554 patients aged ≥ 60 years who were treated for primary OSCC. Overall survival (OS), disease-specific survival, and disease-free survival were the primary outcomes.
Results
Multivariate cox regression analysis showed that high N stage, low hemoglobin level, low body mass index (BMI), and high neutrophil-to-lymphocyte ratio (NLR) showed a poor survival (P < 0.05). A nomogram was constructed with a c-index of 0.702.
Conclusion
A novel clinical signature including hemoglobin level, BMI, and NLR, which are obtained through noninvasive examinations can be used as prognostic indicators in clinical practice for elderly patients with OSCC.
Similar content being viewed by others
References
Siegel RL, Miller KD (2020) Cancer statistics, 2020 . CA Cancer J Clin 70(1):7–30. https://doi.org/10.3322/caac.21590
Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J (2016) Cancer statistics in China, 2015. CA Cancer J Clin 66(2):115–132. https://doi.org/10.3322/caac.21338
López-Sánchez LM, Jurado-Gámez B, Feu-Collado N, Valverde A, Cañas A, Fernández-Rueda JL, Aranda E, Rodríguez-Ariza A (2017) Exhaled breath condensate biomarkers for the early diagnosis of lung cancer using proteomics. Am J Physiol Lung Cell Mol Physiol 313(4):L664-l676. https://doi.org/10.1152/ajplung.00119.2017
Fjortoft I, Furnes B, Hausken T, Storli KE, Eide GE, Sondenaa K (2013) Pre-operative anaemia in colon cancer patients became normal after more than a year post-operatively but did not influence oncological outcome in the final analysis. Scand J Gastroenterol 48(6):663–671. https://doi.org/10.3109/00365521.2013.781216
Szkandera J, Gerger A, Liegl-Atzwanger B, Stotz M, Samonigg H, Ploner F, Stojakovic T, Leithner A, Pichler M (2014) Pre-treatment anemia is a poor prognostic factor in soft tissue sarcoma patients. PLoS ONE 9(9):e107297. https://doi.org/10.1371/journal.pone.0107297
Knight K, Wade S, Balducci L (2004) Prevalence and outcomes of anemia in cancer: a systematic review of the literature. Am J Med 116(Suppl 7A):11s–26s. https://doi.org/10.1016/j.amjmed.2003.12.008
Aoe K, Hiraki A, Maeda T, Katayama H, Fujiwara K, Tabata M, Kiura K, Ueoka H, Tanimoto M (2005) Serum hemoglobin level determined at the first presentation is a poor prognostic indicator in patients with lung cancer. Intern Med 44(8):800–804
Mack JW, Smith TJ (2012) Reasons why physicians do not have discussions about poor prognosis, why it matters, and what can be improved. J Clin Oncol Off J Am Soc Clin Oncol 30(22):2715–2717. https://doi.org/10.1200/jco.2012.42.4564
Sjoquist KM, Renfro LA, Simes RJ, Tebbutt NC, Clarke S, Seymour MT, Adams R, Maughan TS, Saltz L, Goldberg RM, Schmoll HJ, Van Cutsem E, Douillard JY, Hoff PM, Hecht JR, Tournigand C, Punt CJA, Koopman M, Hurwitz H, Heinemann V, Falcone A, Porschen R, Fuchs C, Diaz-Rubio E, Aranda E, Bokemeyer C, Souglakos I, Kabbinavar FF, Chibaudel B, Meyers JP, Sargent DJ, de Gramont A, Zalcberg JR (2018) Personalizing survival predictions in advanced colorectal cancer: the ARCAD nomogram project. J Natl Cancer Inst 110(6):638–648. https://doi.org/10.1093/jnci/djx253
Wang L, Dong T, Xin B, Xu C, Guo M, Zhang H, Feng D, Wang X, Yu J (2019) Integrative nomogram of CT imaging, clinical, and hematological features for survival prediction of patients with locally advanced non-small cell lung cancer. Eur Radiol 29(6):2958–2967. https://doi.org/10.1007/s00330-018-5949-2
van Halteren HK, Houterman S, Verheij CD, Lemmens VE, Coebergh JW (2004) Anaemia prior to operation is related with poorer long-term survival in patients with operable rectal cancer. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol 30(6):628–632. https://doi.org/10.1016/j.ejso.2004.04.014
Zahorec R (2001) Ratio of neutrophil to lymphocyte counts–rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy 102(1):5–14
Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, Clarke SJ (2013) The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol 88(1):218–230. https://doi.org/10.1016/j.critrevonc.2013.03.010
Goldstein D, El-Maraghi RH, Hammel P, Heinemann V, Kunzmann V, Sastre J, Scheithauer W, Siena S, Tabernero J, Teixeira L, Tortora G, Van Laethem JL, Young R, Penenberg DN, Lu B, Romano A, Von Hoff DD (2015) nab-Paclitaxel plus gemcitabine for metastatic pancreatic cancer: long-term survival from a phase III trial. J Natl Cancer Inst. https://doi.org/10.1093/jnci/dju413
Knox JJ, Barrios CH, Kim TM, Cosgriff T, Srimuninnimit V, Pittman K, Sabbatini R, Rha SY, Flaig TW, Page RD, Beck JT, Cheung F, Yadav S, Patel P, Geoffrois L, Niolat J, Berkowitz N, Marker M, Chen D, Motzer RJ (2017) Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC. Ann Oncol Off J Eur Soc Med Oncol 28(6):1339–1345. https://doi.org/10.1093/annonc/mdx075
Yang Y, Liu R, Ren F, Guo R, Zhang P (2018) Prognostic and clinicopathological significance of neutrophil-to-lymphocyte ratio in patients with oral cancer. Biosci Rep. https://doi.org/10.1042/bsr20181550
Huang X, Shu C, Chen L, Yao B (2018) Impact of sex, body mass index and initial pathologic diagnosis age on the incidence and prognosis of different types of cancer. Oncol Rep 40(3):1359–1369. https://doi.org/10.3892/or.2018.6529
Al-Ammar Y, Al-Mansour B, Al-Rashood O, Tunio MA, Islam T, Al-Asiri M, Al-Qahtani KH (2018) Impact of body mass index on survival outcome in patients with differentiated thyroid cancer. Braz J Otorhinolaryngol 84(2):220–226. https://doi.org/10.1016/j.bjorl.2017.02.002
Iyengar NM, Arthur R, Manson JE, Chlebowski RT, Kroenke CH, Peterson L, Cheng TD, Feliciano EC, Lane D, Luo J, Nassir R, Pan K, Wassertheil-Smoller S, Kamensky V, Rohan TE, Dannenberg AJ (2019) Association of body fat and risk of breast cancer in postmenopausal women with normal body mass index: a secondary analysis of a randomized clinical trial and observational study. JAMA Oncol 5(2):155–163. https://doi.org/10.1001/jamaoncol.2018.5327
Kruhlikava I, Kirkegård J, Mortensen FV, Kjær DW (2017) Impact of body mass index on complications and survival after surgery for esophageal and gastro-esophageal-junction cancer. Scand J Surg SJS Off Organ Finn Surg Soc Scand Surg Soc 106(4):305–310. https://doi.org/10.1177/1457496916683097
Gama RR, Song Y, Zhang Q, Brown MC, Wang J, Habbous S, Tong L, Huang SH (2017) Body mass index and prognosis in patients with head and neck cancer. Head Neck 39(6):1226–1233. https://doi.org/10.1002/hed.24760
Jun DH, Kim BJ, Park JH, Kim JG, Chi KC, Park JM, Kim MK, Kang H (2016) Preoperative body mass index may determine the prognosis of advanced gastric cancer. Nutr Cancer 68(8):1295–1300. https://doi.org/10.1080/01635581.2016.1224363
Adachi T, Hinoi T, Kinugawa Y, Enomoto T, Maruyama S, Hirose H, Naito M, Tanaka K, Miyake Y, Watanabe M (2016) Lower body mass index predicts worse cancer-specific prognosis in octogenarians with colorectal cancer. J Gastroenterol 51(8):779–787. https://doi.org/10.1007/s00535-015-1147-z
Funding
This study was supported by Grants from the National Natural Science Foundation of China (81972589 and 81672745) and Program of Innovative Research Team of High-level Local Universities in Shanghai.
Author information
Authors and Affiliations
Contributions
WC, ZL conceived the project and designed the research. CP and ZL did the follow-up work. ZL carried out the data analyzing. WZ interpreted the data and made the figures and wrote the manuscript. The study supervisors are WC. All authors read and approved the final manuscript.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Zhou, W., Peng, C., Liu, Z. et al. A novel clinical signature predicts the survival of elderly patients with oral squamous cell carcinoma. Eur Arch Otorhinolaryngol 279, 391–398 (2022). https://doi.org/10.1007/s00405-021-06786-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-021-06786-6